Neuropathy Pain Management and Your Facility

Roughly 25 to 30 million people in America suffer from peripheral neuropathy. Many of these patients describe neuropathic pain as a shooting or burning feeling. Others talk about numbness, pins-and-needle sensations, or tingling. While a lucky few report the condition disappearing on its own, more experience intermittent pain, increasing in severity and persistence over time. 

In the most extreme cases, patients report unrelenting and severe pain. Neuropathy is caused by cells misfiring, leading to abnormal sensations and changes in nerve function and nerve damage. One of the primary factors contributing to peripheral neuropathy is poorly managed diabetes. 

Neuropathy pain management offers a light at the end of the tunnel for many patients dealing with fluctuating or chronic discomfort. Find out more about options to help your patients take back their lives. ​

---

​The Nuts and Bolts of Neuropathic Pain Diagnosis

Diagnosing peripheral neuropathy involves an interview and physical exam. We’ve refined and honed this process down to its most efficient form and can provide your pharmacy or convenient care clinic with the tips and resources necessary for this process. That way, you don’t need to reinvent the wheel. Instead, patients answer a list of questions, eliciting descriptions of their feelings. Individuals will explain when the pain occurs and whether they can associate any triggers with the condition’s onset. 

Identifying the cause of peripheral neuropathy is the first step in finding the best candidates for treatment with the NeuropaCalm system. Patients with nerve damage stemming from metabolic or systemic reasons (including diabetes) enjoy 93 percent improvement. Those with idiopathic neuropathy have a success rate of 50 percent. As a result, your pharmacy or clinic should focus on those with peripheral neuropathy associated with diabetes. That’s more than 37 million people in the United States alone.

​Our Neuropathy Pain Management Care Program

Traditionally, physicians have relied on antidepressant and anticonvulsant drugs as the first (and often the only) treatment options against neuropathy. Some may also prescribe non-steroidal anti-inflammatory drugs (NSAIDs). These may include Aleve, Motrin, or a prescription painkiller. But patients need to know that standard pain treatments aren’t the be-all, end-all for peripheral neuropathy. They can even make the problem worse. Unfortunately, because of the ineffective treatments many patients have encountered, they may have little to no expectation that their condition will improve. 

As a result, gaining patient trust in the process is a significant step in the right direction for pharmacists and clinicians in this space. After all, patients need to buy into the process to gain the most from the NeuropaCalm Care Program. Our diagnosis and treatment process considers the need for patient buy-in, and we have the resources your pharmacy or clinic needs to ensure patients see the best results possible.

​Why Pharmacies and Clinics Need to Address Neuropathy

​Treating the underlying disease that contributes to neuropathy, such as diabetes, is vital to better outcomes. By managing conditions like diabetes effectively, you can help patients thwart future nerve damage. You also play a unique role in ensuring patients don’t fall through the cracks. People living with diabetes visit your facility every day, which translates into zero acquisition costs. 

Are you ready to learn about our unique approach to treating peripheral neuropathy? The NeuropaCalm Care Program combines cutting-edge therapies for incredible results. Our multidisciplinary strategy offers the most significant relief available on the market today. Learn more about managing neuropathy with the NeuropaCalm Care Program.  ​